Medicare AdvantageDocumentationLow impact
[California] Statin Use in Persons with Diabetes: closing the statin gap for adults aged 40 to 75 with diabetes
Anthem BCBS·CA · Endocrinology, Cardiology, Internal Medicine +2 more·Provider Bulletin
Effective date
May 1, 2026
We identified it
May 3, 2026
Summary
Anthem Blue Cross is emphasizing statin therapy for Medicare Advantage members aged 40-75 with diabetes as part of the SUPD (Statin Use in Persons with Diabetes) Star measure. This is a quality initiative bulletin—not a billing code or coverage change—designed to improve provider awareness and documentation of statin use for cardiovascular risk management in this population.
Action Required
No immediate billing system changes required. This is an informational provider bulletin. However, billing and clinical teams should: (1) Ensure accurate documentation of statin prescriptions and patient statin use status in the medical record for Medicare Advantage members aged 40-75 with diabetes to support SUPD Star measure reporting; (2) Coordinate with providers to identify and close statin therapy gaps through panel reviews before patient visits; (3) Monitor pharmacy claims to confirm first-fill completion and follow up if claims do not appear; (4) Document exclusions and true statin intolerance clearly in the chart. Failure to maintain clean documentation of statin use may negatively impact SUPD Star measure performance, affecting plan quality ratings and potential bonus payments.